Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 14 | 2023 | 230 | 4.520 |
Why?
|
| Stroke Volume | 2 | 2020 | 97 | 1.320 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 105 | 1.260 |
Why?
|
| Patient Readmission | 2 | 2018 | 74 | 1.150 |
Why?
|
| Myocarditis | 2 | 2020 | 17 | 1.040 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 104 | 0.800 |
Why?
|
| Telemetry | 2 | 2010 | 14 | 0.740 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 221 | 0.730 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 88 | 0.710 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 50 | 0.650 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 465 | 0.630 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 84 | 0.620 |
Why?
|
| Digoxin | 1 | 2017 | 6 | 0.620 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 11 | 0.620 |
Why?
|
| Dyslipidemias | 1 | 2016 | 42 | 0.560 |
Why?
|
| Medicaid | 1 | 2017 | 102 | 0.560 |
Why?
|
| Quality of Life | 1 | 2020 | 459 | 0.550 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 77 | 0.550 |
Why?
|
| Humans | 33 | 2024 | 34853 | 0.520 |
Why?
|
| Atherosclerosis | 1 | 2016 | 131 | 0.520 |
Why?
|
| Middle Aged | 18 | 2020 | 9642 | 0.480 |
Why?
|
| Risk Factors | 9 | 2020 | 3414 | 0.480 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 446 | 0.450 |
Why?
|
| Electrocardiography | 3 | 2011 | 154 | 0.410 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 2 | 0.400 |
Why?
|
| Hospitalization | 4 | 2017 | 370 | 0.390 |
Why?
|
| Patient Admission | 1 | 2010 | 40 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 5 | 2021 | 187 | 0.370 |
Why?
|
| United States | 6 | 2023 | 3894 | 0.370 |
Why?
|
| Coronary Angiography | 3 | 2011 | 92 | 0.360 |
Why?
|
| Aged | 12 | 2020 | 6448 | 0.350 |
Why?
|
| Male | 17 | 2020 | 18870 | 0.340 |
Why?
|
| Time Factors | 3 | 2018 | 1681 | 0.330 |
Why?
|
| Cardiovascular Diseases | 2 | 2006 | 628 | 0.330 |
Why?
|
| Adult | 11 | 2020 | 11034 | 0.320 |
Why?
|
| Heart Diseases | 1 | 2009 | 99 | 0.320 |
Why?
|
| Female | 17 | 2020 | 19873 | 0.320 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 7 | 0.300 |
Why?
|
| Retrospective Studies | 5 | 2021 | 1961 | 0.300 |
Why?
|
| Incidence | 2 | 2022 | 882 | 0.300 |
Why?
|
| Coronary Vessels | 2 | 2011 | 93 | 0.290 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 213 | 0.290 |
Why?
|
| Treatment Outcome | 4 | 2018 | 1349 | 0.280 |
Why?
|
| Heart Block | 1 | 2004 | 2 | 0.260 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 9 | 0.260 |
Why?
|
| Cardiac Tamponade | 1 | 2004 | 4 | 0.260 |
Why?
|
| American Heart Association | 1 | 2023 | 17 | 0.240 |
Why?
|
| Health Facilities | 1 | 2023 | 23 | 0.240 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 151 | 0.230 |
Why?
|
| Prognosis | 3 | 2020 | 707 | 0.230 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2003 | 19 | 0.230 |
Why?
|
| Troponin T | 1 | 2022 | 8 | 0.220 |
Why?
|
| Troponin I | 1 | 2022 | 18 | 0.220 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 30 | 0.220 |
Why?
|
| Risk Assessment | 3 | 2017 | 727 | 0.220 |
Why?
|
| Thrombosis | 1 | 2003 | 61 | 0.220 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 19 | 0.210 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 608 | 0.200 |
Why?
|
| Georgia | 4 | 2021 | 155 | 0.200 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 13 | 0.200 |
Why?
|
| Disease Management | 1 | 2021 | 61 | 0.190 |
Why?
|
| Hypertension | 4 | 2011 | 770 | 0.180 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 423 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 570 | 0.160 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 531 | 0.160 |
Why?
|
| Prevalence | 3 | 2016 | 1425 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 46 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 132 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 211 | 0.160 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 7 | 0.160 |
Why?
|
| Cause of Death | 1 | 2018 | 154 | 0.150 |
Why?
|
| Propensity Score | 1 | 2017 | 40 | 0.150 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 54 | 0.150 |
Why?
|
| Young Adult | 2 | 2017 | 4012 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2016 | 517 | 0.140 |
Why?
|
| Comorbidity | 2 | 2016 | 606 | 0.140 |
Why?
|
| Medicare | 1 | 2017 | 188 | 0.130 |
Why?
|
| Urban Population | 2 | 2010 | 318 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 228 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 188 | 0.130 |
Why?
|
| Logistic Models | 2 | 2016 | 894 | 0.130 |
Why?
|
| Disease Progression | 1 | 2017 | 580 | 0.130 |
Why?
|
| New York City | 2 | 2006 | 212 | 0.120 |
Why?
|
| Blood Pressure | 4 | 2011 | 613 | 0.120 |
Why?
|
| Age Factors | 1 | 2016 | 1007 | 0.110 |
Why?
|
| Heart Failure, Systolic | 1 | 2011 | 4 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2019 | 1353 | 0.100 |
Why?
|
| Health Policy | 2 | 2023 | 149 | 0.100 |
Why?
|
| Aortography | 1 | 2011 | 10 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2011 | 64 | 0.100 |
Why?
|
| Organizational Policy | 1 | 2010 | 20 | 0.100 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 11 | 0.090 |
Why?
|
| Health Promotion | 2 | 2024 | 588 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 2333 | 0.090 |
Why?
|
| Length of Stay | 1 | 2010 | 184 | 0.090 |
Why?
|
| Community Networks | 2 | 2006 | 98 | 0.080 |
Why?
|
| Health Literacy | 1 | 2010 | 100 | 0.080 |
Why?
|
| Echocardiography | 2 | 2011 | 144 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 142 | 0.080 |
Why?
|
| Exercise | 1 | 2013 | 524 | 0.080 |
Why?
|
| Patient Selection | 1 | 2009 | 154 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 17 | 0.080 |
Why?
|
| Defibrillators, Implantable | 1 | 2007 | 34 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2006 | 62 | 0.070 |
Why?
|
| Adolescent | 1 | 2017 | 5035 | 0.070 |
Why?
|
| Medical Audit | 1 | 2006 | 24 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 27 | 0.070 |
Why?
|
| Physical Examination | 1 | 2006 | 40 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 195 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2010 | 583 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 103 | 0.060 |
Why?
|
| Medical Assistance | 1 | 2023 | 3 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 30 | 0.060 |
Why?
|
| Writing | 1 | 2023 | 33 | 0.060 |
Why?
|
| Hirudin Therapy | 1 | 2003 | 1 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 205 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 7 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2005 | 233 | 0.060 |
Why?
|
| Heart Atria | 1 | 2003 | 27 | 0.060 |
Why?
|
| Schools, Medical | 1 | 2005 | 192 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2023 | 158 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 111 | 0.050 |
Why?
|
| Heart | 1 | 2024 | 178 | 0.050 |
Why?
|
| Warfarin | 1 | 2003 | 59 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 254 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 97 | 0.050 |
Why?
|
| Registries | 2 | 2019 | 330 | 0.050 |
Why?
|
| Transportation | 1 | 2021 | 26 | 0.050 |
Why?
|
| Home Care Services | 1 | 2021 | 29 | 0.050 |
Why?
|
| Social Work | 1 | 2021 | 45 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2021 | 165 | 0.040 |
Why?
|
| Health Education | 1 | 2021 | 304 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2561 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1003 | 0.040 |
Why?
|
| Acute Disease | 1 | 2016 | 141 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2013 | 322 | 0.030 |
Why?
|
| Chest Pain | 1 | 2011 | 36 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 73 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 469 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 292 | 0.020 |
Why?
|
| Social Support | 1 | 2010 | 356 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 19 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 103 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 48 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2005 | 27 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2005 | 151 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 63 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 223 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 212 | 0.020 |
Why?
|
| Alleles | 1 | 2005 | 284 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2005 | 136 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 430 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 229 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2005 | 283 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 528 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 638 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 537 | 0.010 |
Why?
|